ProKidney Corp (NASDAQ:PROK) price on Friday, April 11, rose 19.20% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.73.
A look at the stock’s price movement, the close in the last trading session was $0.61, moving within a range at $0.5974 and $0.7313. The beta value (5-Year monthly) was 1.589. Turning to its 52-week performance, $4.44 and $0.46 were the 52-week high and 52-week low respectively. Overall, PROK moved -23.24% over the past month.
ProKidney Corp’s market cap currently stands at around $214.05 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-16.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PROK is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
6 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 5 recommend PROK as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
PROK’s current price about -11.96% and -36.12% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 39.68, while 7-day volatility ratio is 26.72% and 16.07% in the 30-day chart. Further, ProKidney Corp (PROK) has a beta value of 1.69, and an average true range (ATR) of 0.12. Analysts have given the company’s stock an average 52-week price target of $5, forecast between a low of $3 and high of $6. Looking at the price targets, the low is -310.96% off current price level while to achieve the yearly target high, price needs to move -721.92%. Nonetheless, investors will most likely welcome a -584.93% jump to $5 which is the analysts’ median price.
If we refocus on ProKidney Corp (NASDAQ:PROK), historical trading data shows that trading volumes averaged 1.17 over the past 10 days and 562.61K over the past 3 months. The company’s latest data on shares outstanding shows there are 128.05 million shares.
The 27.84% of ProKidney Corp’s shares are in the hands of company insiders while institutional holders own 44.18% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 11.82 million on 2025-03-14, giving us a short ratio of 21.39. The data shows that as of 2025-03-14 short interest in ProKidney Corp (PROK) stood at 1010.0000000000001 of shares outstanding, with shares short rising to 11.75 million registered in 2025-02-14. Current price change has pushed the stock -56.73% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PROK stock continues to rise going into the next quarter.
